Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan
- Publication date
- 1 January 2003
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'